FMC to commercialize Chr. Hansen’s biological products

Date:08-24-2011

FMC announced its Agricultural Products Group has entered into two exclusive agreements covering global development and supply of Chr. Hansen biological products for agricultural and ornamental markets. FMC will begin commercialization this year of Chr. Hansen's Nemix bacillus product in Brazil and start development for new biological standalone and combination products in the Americas and key agricultural markets.

Under the agreements, FMC will access Chr. Hansen's large library of existing bacillus products to evaluate and develop other biological products for use in agriculture as nematicides and plant health promoters. Chr. Hansen will supply biological materials for products that FMC commercializes under the agreements. Terms of the agreements were not disclosed.

"The Chr. Hansen biological products are complementary to FMC's portfolio of crop protection products and offer additional solutions to growers in FMC's focus markets," said Milton Steele, president, FMC Agricultural Products Group. "This relationship opens exciting new opportunities for FMC's Agricultural Products Group and is clearly aligned with our growth strategy by expanding in adjacent spaces to chemical crop protection markets."